Vaidya Sane

Q3 FY25 Earnings Call Analysis

Healthcare Equipment & Supplies

Full Stock Analysis
fundraise: Yescapex: Yesrevenue: Category 2margin: Category 1orderbook: Yes
💰

fundraise

Any current/future new fundraising through debt or equity?

- The company has issued 40 lakh preferential warrants to institutional investors, pending NSE approval for 25% payment to be received. - No new equity fundraising announced beyond this; the receipt of funds depends on regulatory approval. - No mention of fresh debt-raising plans in the current discussion or future outlook. - Existing capital raise proceeds from warrants are primarily earmarked for hospital expansions (Khopoli and Nagpur). - The company is focusing on internal cash flow generation to fund growth, indicating limited reliance on external debt.
🏗️

capex

Any current/future capex/capital investment/strategic investment?

- **Current/future CAPEX plans:** - Expansion of hospitals at Khopoli (100 extra beds) and Nagpur (80 beds) with an estimated investment of INR 25-30 crores. - Vadodara hospital expansion on a rental model; no construction CAPEX expected but installation costs applicable. - Ongoing construction started for Khopoli hospital expansion; Nagpur hospital CAPEX to commence in 3-4 months. - Capacity expansion at Nagpur hospital adding 5 beds, investment approx. INR 55 lakhs. - Launch of Urja Neuro Care facility focused on integrative neuro treatments, estimated cost about INR 1.8 crores. - Plans to increase bed capacity to around 350-370 beds in next 12-15 months. - Aim to have about 1000 beds nationwide in 2-3 years. - **Strategic investments:** - International expansion via collaboration with Maxura Healthcare in Malaysia to establish an Ayurvedic therapy center. - Investment in marketing and branding (~INR 7 crores amortized over 5 years). - Strengthening insurance empanelment to improve hospital occupancy. Overall, aggressive capacity expansion and strategic partnerships are major investment focuses.
📊

revenue

Future growth expectations in sales/revenue/volumes?

- FY '26 expected revenue: INR 115-120 crores. - FY '27 projected sales: Around INR 180 crores; INR 50-55 crores from hospitals, INR 125-135 crores from clinics, with potential to surpass this figure. - FY '28 sales target: INR 280 crores planned, with aim to surpass and possibly reach INR 320-350 crores. - EBITDA margins expected to increase to 30%-35% by FY '28 if INR 280 crore turnover is achieved. - Revenue growth drivers include increased patient footfall in clinics, expansion of hospital bed capacity from current 110 beds to 350+ beds by FY '28. - Scale-up of Madhavprash sales from 15,000-20,000 units/month currently to target of 1 lakh units/month in next 24 months. - Expansion plans include adding 6 more hospitals mostly in Gujarat, Maharashtra, Rajasthan, and potential franchise hospital upgrades. - Overall growth focus on clinics, hospitals, food/nutritional products, and wellness centers.
📈

margin

Future growth expectations in earnings/operating earnings/profits/EPS?

- FY '26 revenue expected at INR 115-120 crores, with 20% growth and EBITDA margins around 17-18%. - EBITDA margin targeted to steadily increase, aiming for ~20% by FY '28. - PAT margins anticipated to rise to about 10-12% by FY '28. - By FY '28, revenue potential estimated at INR 280 crores or more, possibly reaching INR 320-350 crores, with roughly 30-35% EBITDA margin. - EBITDA anticipated to grow 1.5x to 2x by FY '28 compared to current, with EBITDA above 30%. - EPS growth aligned with revenue and profit increases; EPS was INR 4.56 in H1 FY '26, expected to improve with scaling. - Confidence in maintaining operational discipline, sustainable growth, and expanding patient base to drive earnings.
📋

orderbook

Current/ Expected Orderbook/ Pending Orders?

The transcript does not explicitly mention current or expected order book or pending orders details. However, relevant points indicating future business and growth pipeline include: - Expansion plans for hospitals with an increase from 110 beds to approximately 350-370 beds in the next 12-15 months across Khopoli, Nagpur, Vadodara, and Vizag. - Targeting 1,000 beds nationwide in 2 to 3 years through organic expansion and franchise hospital upgrades. - Plans to add 40 to 50 new clinics in the current year and 70 to 80 clinics next year. - Ongoing construction and CAPEX of about INR 25-30 crores for capacity expansion at Khopoli and Nagpur hospitals. - Expecting sales to grow to around INR 115-120 crores for FY '26, INR 180 crores for FY '27, and INR 280 crores+ for FY '28. - Active franchise clinics showing conversion into hospitals (e.g., Kolhapur 5-bed hospital). No specific order book or pending order values were disclosed.